Detalles de la búsqueda
1.
Relationship Between Dissociation and Antidepressant Effects of Esketamine Nasal Spray in Patients With Treatment-Resistant Depression.
Int J Neuropsychopharmacol;
25(4): 269-279, 2022 04 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35022754
2.
A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia.
Int J Neuropsychopharmacol;
25(3): 238-251, 2022 03 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34791283
3.
Comparison of Long-Term Efficacy and Safety of Esketamine Nasal Spray Plus Oral Antidepressant in Younger Versus Older Patients With Treatment-Resistant Depression: Post-Hoc Analysis of SUSTAIN-2, a Long-Term Open-Label Phase 3 Safety and Efficacy Study.
Am J Geriatr Psychiatry;
30(5): 541-556, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34750057
4.
Assessing treatment benefit in the presence of placebo response using the sequential parallel comparison design.
Stat Med;
41(12): 2166-2190, 2022 05 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35184326
5.
Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II).
Int J Neuropsychopharmacol;
24(1): 22-31, 2021 01 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-32861217
6.
Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression-TRANSFORM-3.
Am J Geriatr Psychiatry;
28(2): 121-141, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31734084
7.
Continual reassessment method with regularization in phase I clinical trials.
J Biopharm Stat;
30(6): 964-978, 2020 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32926652
8.
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1).
Int J Neuropsychopharmacol;
22(10): 616-630, 2019 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31290965
9.
Guidelines for the Content of Statistical Analysis Plans in Clinical Trials.
JAMA;
318(23): 2337-2343, 2017 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29260229
10.
Brief Report: Mediation Analysis with an Ordinal Outcome.
Epidemiology;
27(5): 651-5, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27258323
11.
Defining Clinical Trial Estimands: A Practical Guide for Study Teams with Examples Based on a Psychiatric Disorder.
Ther Innov Regul Sci;
57(5): 911-939, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37244885
12.
A randomized trial of paliperidone palmitate and risperidone long-acting injectable in schizophrenia.
Int J Neuropsychopharmacol;
15(1): 107-18, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21777507
13.
On efficient two-stage adaptive designs for clinical trials with sample size adjustment.
J Biopharm Stat;
22(4): 617-40, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22651105
14.
On adaptive error spending approach for group sequential trials with random information levels.
J Biopharm Stat;
22(4): 687-99, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22651109
15.
Doubly randomized delayed-start design for enrichment studies with responders or nonresponders.
J Biopharm Stat;
22(4): 737-57, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22651112
16.
Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Studies.
CNS Drugs;
35(7): 781-794, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34235612
17.
Paliperidone palmitate, a potential long-acting treatment for patients with schizophrenia. Results of a randomized, double-blind, placebo-controlled efficacy and safety study.
Int J Neuropsychopharmacol;
13(5): 635-47, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19941696
18.
A randomized, placebo-controlled study to assess the efficacy and safety of 3 doses of paliperidone palmitate in adults with acutely exacerbated schizophrenia.
J Clin Psychopharmacol;
30(3): 235-44, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20473057
19.
A randomized, placebo- and active-controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder.
Bipolar Disord;
12(3): 230-43, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20565430
20.
One-year open-label safety and efficacy study of paliperidone extended-release tablets in patients with schizophrenia.
CNS Spectr;
15(8): 506-14, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20703197